Table 3.
Characteristic | Lung metastasis (n = 30) | Benign (n = 10) | P value |
Type of lung operation | |||
VATS | 25 (83.3) | 9 (90.0) | 0.526 |
Open | 5 (16.6) | 1 (10.0) | |
Lung operation-related complications | 0 | 0 | |
Number of lung nodules | |||
1 | 18 (60.0) | 6 (60.0) | 0.547 |
2 | 10 (33.3) | 2 (20.0) | |
3 | 2 (6.6) | 2 (20.0) | |
Size of lung nodules (mm) | 11.8 ± 7.5 | 11.8 ± 7.0 | 0.881 |
Bilaterality | |||
Unilateral | 27 (90.0) | 10 (100) | 0.411 |
Bilateral | 3 (10.0) | 0 | |
Pre-thoracotomy serum CEA elevation | 0 | 0 | |
Pre-thoracotomy serum CA19-9 elevation | 0 | 0 |
CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; VATS: Video-assisted thoracoscopic surgery.